Edition:
United Kingdom

AVROBIO Inc (AVRO.OQ)

AVRO.OQ on NASDAQ Stock Exchange Global Select Market

15.00USD
7:39pm GMT
Change (% chg)

$0.32 (+2.18%)
Prev Close
$14.68
Open
$14.80
Day's High
$15.05
Day's Low
$14.36
Volume
43,071
Avg. Vol
37,780
52-wk High
$53.70
52-wk Low
$11.85

Chart for

About

AVROBIO, Inc. is a clinical stage gene therapy company. The Company is focused on developing curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. Its gene therapies employ hematopoietic stem cells that are extracted from the patient and then modified with lentiviral vectors to insert a... (more)

Overall

No Ratios Available.

Financials

  AVRO.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -- -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

Earnings vs. Estimates